Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

US7592358B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Dirk Stenkamp · Biberach, DE
• Stephan Georg Mueller · Warthausen, DE
• Philipp Lustenberger · Warthausen, DE
• Thorsten Lehmann-Lintz · Ochsenhausen, DE
• Gerald Juergen Roth · Biberach, DE
• Klaus Rudolf · Warthausen, DE
• Marcus Schindler · Schwäbisch Hall, DE
• Leo Thomas · Biberach, DE
• Ralf Lotz · Schemmerhofen, DE

Key dates

• Filing date: Apr 13, 2005
• Grant date: Sep 22, 2009
• Expiry date: Mar 31, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D451/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Alkyne compounds having MCH-receptor antagonistic activity, which are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.